StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
RELAXO.BO$328.30-4.70%
Fair $328.30+0.0%

RELAXO.BO

Relaxo Footwears Limited

Consumer Cyclical / Footwear & AccessoriesBSE

$328.30

-16.15 (-4.70%)

Fairly Valued+0.0%Fair Value $328.30Fund rank 34/100 · Data gapFallback financials|
SA 35/D
F-Score: 4/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.1B · quality 69.3/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 50/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years
Thesis & Journal · RELAXO.BOLocal privado en este navegador · Relaxo Footwears Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$81.7B

P/E

45.6x

↑

EV/EBITDA

20.0x

↑

ROE

8.1%

↑

Gross Margin

59.2%

↑

Debt/Equity

0.11

↓
52-Week Range$328
$237$531

TradingView lightweight chart

RELAXO.BO price, volumen y niveles de valoración

Último $327.50Periodo +35305.4%
Fair value: $328.30

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-0.8%

FCF CAGR

-0.6%

FCF margin

7.8%

FCF / Net income

1.18x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $27.02B · net income $1.79B · FCF $2.11B

2023-FY → 2026-FY

Gross margin

59.2%+7.7% pts

Operating margin

8.0%+0.2% pts

Net margin

6.6%+1.0% pts

FCF margin

7.8%+0.0% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$27.02B$27.02B$27.90B$28.94B$27.64B
Net Income$1.79B$1.79B$1.70B$2.00B$1.54B
EBITDA$4.20B$4.20B$4.09B$4.35B$3.54B
EPS——6.848.056.21
Gross Margin59.2%59.2%58.8%57.6%51.5%
Operating Margin8.0%8.0%8.0%9.0%7.8%
Net Margin6.6%6.6%6.1%6.9%5.6%
Balance Sheet
Debt/Equity0.110.110.100.100.09
Cash Flow
Free Cash Flow$2.11B$2.11B$2.90B$-142.7M$2.15B
Returns
ROE8.1%8.1%8.1%10.0%8.3%
Valuation
P/E45.6045.6060.92104.32134.27
EV/EBITDA19.9619.9625.8448.4159.04
P/B3.703.704.9510.4511.19
Growth & Yield
Revenue Growth-3.1%-3.1%-3.6%4.7%—
EPS Growth——-15.0%29.6%—
Dividend Yield1.0%1.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -25.7%

Total return

-25.7%

Start / end P/E

n/dx → n/dx

EPS bridge

6.84 → n/d

Residual

-26.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.0%
Residual / FX / buybacks / cross-term-26.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.